Ulcerative Colitis (UC) is a chronic inflammatory bowel disease affecting the colon lining, and its incidence is rising globally, especially in industrialized countries. The causes of UC are ...

Share on Pinterest Officials say Zeposia could reduce symptoms of ulcerative colitis in adults. Pixels Effect/Getty Images Federal regulators have approved the new drug Zeposia for treating ...

It is estimated that more than 5 million people worldwide suffer from ulcerative colitis, a chronic inflammation of the colon that often progresses in stages whose causes have not yet been fully ...

The resulting inflammation, in turn, causes the characteristic colitis ... transmissible from T-bet-deficient adult mice with ulcerative colitis to other adults with normal T-bet, through fecal ...

“Allura Red,” on intestinal inflammation and whether it could cause inflammatory bowel disease (IBD) and colitis. Using an animal model, they found that chronic but not intermittent ...

AbbVie’s Skyrizi (risankizumab-rzaa) has been approved by the European Commission (EC) to treat adults with moderately-to-severely active ulcerative colitis (UC). The interleukin-23 inhibitor has ...